• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease.

作者信息

Janetzky B, Hauck S, Youdim M B, Riederer P, Jellinger K, Pantucek F, Zöchling R, Boissl K W, Reichmann H

机构信息

Department of Neurology, University of Würzburg, Germany.

出版信息

Neurosci Lett. 1994 Mar 14;169(1-2):126-8. doi: 10.1016/0304-3940(94)90372-7.

DOI:10.1016/0304-3940(94)90372-7
PMID:8047266
Abstract

Substantia nigra pars compacta of seven patients who had died of Parkinson's disease, has been investigated for the iron-depending aconitase (reactions I and II). In addition we analysed respiratory chain enzymes. While complex I activity of the respiratory chain was significantly reduced, other enzymes of this pathway were unaltered. The citric acid cycle enzyme aconitase (reactions I and II) showed no difference between patients and controls. Thus this ferrous iron dependent and oxidatively sensitive enzyme is not affected by the unphysiological high amount of ferric iron and the 'oxidative stress' present in substantia nigra of parkinsonian patients.

摘要

相似文献

1
Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease.
Neurosci Lett. 1994 Mar 14;169(1-2):126-8. doi: 10.1016/0304-3940(94)90372-7.
2
Iron-dependent enzymes in Parkinson's disease.帕金森病中的铁依赖性酶。
J Neural Transm Suppl. 1995;46:157-64.
3
Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.
J Neurochem. 1990 Dec;55(6):2142-5. doi: 10.1111/j.1471-4159.1990.tb05809.x.
4
Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress.过氧化氢对三羧酸循环酶的抑制作用:α-酮戊二酸脱氢酶在氧化应激下限制NADH生成中的关键作用。
J Neurosci. 2000 Dec 15;20(24):8972-9. doi: 10.1523/JNEUROSCI.20-24-08972.2000.
5
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.帕金森病1-甲基-4-苯基-1,2,3,6-四氢吡啶/丙磺舒渐进性神经退行性小鼠模型黑质致密部神经元凋亡的早期迹象。
Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14.
6
Brain peroxidase and catalase in Parkinson disease.
Arch Neurol. 1975 Feb;32(2):114-8. doi: 10.1001/archneur.1975.00490440064010.
7
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.帕金森病患者脑死后黑质中铁(III)及总铁含量增加。
J Neural Transm. 1988;74(3):199-205. doi: 10.1007/BF01244786.
8
Iron-sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson's disease.铁硫酶介导实验性帕金森病中的线粒体超氧化物毒性。
J Neurochem. 2004 Sep;90(5):1076-84. doi: 10.1111/j.1471-4159.2004.02567.x.
9
Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.帕金森病中黑质神经元树突的病理变化:一项高尔基染色研究
Histol Histopathol. 1991 Jul;6(3):373-80.
10
Characterization of the human mitochondrial aconitase gene (ACO2).人类线粒体乌头酸酶基因(ACO2)的特性分析。
Gene. 1998 Jun 15;213(1-2):205-18. doi: 10.1016/s0378-1119(98)00188-7.

引用本文的文献

1
Revolutionizing our understanding of Parkinson's disease: Dr. Heinz Reichmann's pioneering research and future research direction.颠覆帕金森病认知的革命:海因茨·赖希曼博士的开拓性研究与未来研究方向。
J Neural Transm (Vienna). 2024 Dec;131(12):1367-1387. doi: 10.1007/s00702-024-02812-z. Epub 2024 Aug 7.
2
Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential.帕金森病中的线粒体功能障碍——具有治疗潜力的关键疾病标志。
Mol Neurodegener. 2023 Nov 11;18(1):83. doi: 10.1186/s13024-023-00676-7.
3
Role of Hydroxytyrosol and Oleuropein in the Prevention of Aging and Related Disorders: Focus on Neurodegeneration, Skeletal Muscle Dysfunction and Gut Microbiota.
羟基酪醇和橄榄苦苷在预防衰老及相关疾病中的作用:聚焦于神经退行性变、骨骼肌功能障碍和肠道微生物群。
Nutrients. 2023 Apr 4;15(7):1767. doi: 10.3390/nu15071767.
4
Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease.靶向线粒体作为帕金森病的一种治疗方法。
Cell Mol Neurobiol. 2023 May;43(4):1499-1518. doi: 10.1007/s10571-022-01265-w. Epub 2022 Aug 11.
5
Hallmarks and Molecular Tools for the Study of Mitophagy in Parkinson's Disease.帕金森病中自噬的标志和分子工具研究。
Cells. 2022 Jul 2;11(13):2097. doi: 10.3390/cells11132097.
6
Association Between Mitochondrial Function and Rehabilitation of Parkinson's Disease: Revealed by Exosomal mRNA and lncRNA Expression Profiles.线粒体功能与帕金森病康复之间的关联:通过外泌体mRNA和lncRNA表达谱揭示
Front Aging Neurosci. 2022 Jun 16;14:909622. doi: 10.3389/fnagi.2022.909622. eCollection 2022.
7
Robustness of the Krebs Cycle under Physiological Conditions and in Cancer: New Clues for Evaluating Metabolism-Modifying Drug Therapies.生理条件下及癌症状态下三羧酸循环的稳健性:评估代谢修饰药物疗法的新线索
Biomedicines. 2022 May 22;10(5):1199. doi: 10.3390/biomedicines10051199.
8
Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer's Disease.Nrf2信号通路在帕金森病和阿尔茨海默病氧化损伤及线粒体功能障碍中的作用
Antioxidants (Basel). 2021 Jul 2;10(7):1069. doi: 10.3390/antiox10071069.
9
Understanding the Multiple Role of Mitochondria in Parkinson's Disease and Related Disorders: Lesson From Genetics and Protein-Interaction Network.了解线粒体在帕金森病及相关疾病中的多重作用:来自遗传学和蛋白质相互作用网络的启示
Front Cell Dev Biol. 2021 Apr 1;9:636506. doi: 10.3389/fcell.2021.636506. eCollection 2021.
10
Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson's disease? A critical reappraisal.在帕金森病中,复合物 I 活性与黑质神经元丧失之间是否存在特殊关系?批判性再评价。
Brain Res. 2021 Sep 15;1767:147434. doi: 10.1016/j.brainres.2021.147434. Epub 2021 Mar 19.